JAMA 7 Nov 2012 Vol 308 1747 Big trials: don’t you love ‘em? James Penston doesn’t, arguing in his book stats.con (2010) that we have been duped into adopting interventions […]
Richard Lehman’s weekly review of medical journals
Richard Lehman’s journal review—5 November 2012
NEJM 1 Nov 2012 Vol 367 1677 Cancer screening campaigns—getting past uninformative persuasion is a topical subject on both sides of the Atlantic. Nobody writes better about it than Steven […]
Richard Lehman’s journal review—29 October 2012
JAMA 24-31 Oct 2012 Vol 308 1660 Medicine is full of surprises, but sometimes things are just the way you thought they were. Back in 1973, I was taught that […]
Richard Lehman’s journal review—22 October 2012
JAMA 17 Oct 2012 Vol 308 1545 “Between 1988 and 2010, favorable trends in lipid levels have occurred among adults in the United States.” That may seem pretty amazing, but […]
Richard Lehman’s journal review—15 October 2012
JAMA 10 Oct 2012 Vol 308 1433 A Viewpoint piece by three Dutch radiologists explores the possible added benefits that could arise if developed countries introduced lung cancer screening using […]
Richard Lehman’s journal review—8 October 2012
JAMA 3 Oct 2012 Vol 308 1333 Can vitamin D prevent the common cold? The answer is almost certainly yes, depending on baseline levels. If you run a trial in […]
Richard Lehman’s journal review—1 October 2012
Arch Intern Med 24 Sep 2012 Vol 172 Of Exercise I sing, and that benignant sweat Which from six thousand diabetic brows Exudes. My pen, Hygeia, speed! To save That […]
Richard Lehman’s journal review—24 September 2012
JAMA 19 Sep 2012 Vol 308 1122 This week’s JAMA is devoted to obesity. It’s a bit like global warming: we can see it happening around us, we can foresee […]
Richard Lehman’s journal review—17 September 2012
JAMA 12 Sep 2012 Vol 308 981 “Considering the cost, invasiveness, inpatient requirement, and morbidity of bariatric surgery, a truly intensive nonsurgical comparison group is not only justifiable but also […]
Richard Lehman’s journal review – 10 September 2012
JAMA 5 Sep 2012 Vol 308 869 Cancer, multiple sclerosis, stroke: do you want your patients to get the benefit of new drugs for these conditions as soon as possible? […]